Key Takeaways

Starting dose: 0.25mg once weekly for the first 4 weeks
Maintenance dose: 2.4mg weekly for weight loss (Wegovy), 1mg or 2mg for diabetes (Ozempic)
Titration schedule: Increase every 4 weeks: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Half-life: Approximately 7 days (1 week), supporting once-weekly dosing
Clinical efficacy: STEP 1 trial showed 14.9% average weight loss at 68 weeks

✓ FDA-Approved: Semaglutide is FDA-approved as Wegovy (2.4mg for weight management) and Ozempic (up to 2mg for type 2 diabetes). The dosing information below covers both approved indications and compounded peptide use.

Semaglutide GLP-1 mechanism of action diagram showing brain, stomach, and pancreas

GLP-1 mechanism: appetite suppression, slowed gastric emptying, and improved insulin response

Semaglutide Dosing Schedule Overview

Semaglutide is a GLP-1 receptor agonist used to treat obesity and type 2 diabetes. It was the first GLP-1 to gain widespread use for weight loss, and getting the dosing right makes a real difference in both results and side effects.

The dosing protocol takes 16-20 weeks to reach the full maintenance dose. This slow ramp-up matters: studies show faster titration leads to higher rates of nausea, vomiting, and people quitting treatment entirely.

📋 Brand Differences: Wegovy (for weight loss) goes up to a recommended 2.4mg maintenance dose, with a 7.2mg maximum. Ozempic (for diabetes) goes up to 2mg. Both are the same molecule (semaglutide) but marketed for different indications. Compounded semaglutide follows the Wegovy protocol for weight loss.

Standard Titration Schedule (Wegovy Protocol)

Phase	Weeks	Weekly Dose	Purpose
Initial	1-4	0.25mg	GI adaptation phase
Escalation 1	5-8	0.5mg	Begin therapeutic effect
Escalation 2	9-12	1mg	Therapeutic dose for diabetes
Escalation 3	13-16	1.7mg	Approaching maintenance
Maintenance	17+	2.4mg	Full therapeutic dose for weight loss

Source: Wegovy FDA Prescribing Information

Use our free semaglutide dosing calculator to visualize your specific protocol and see projected drug levels over time.

Understanding Semaglutide: Mechanism and Pharmacology

What it is: Semaglutide is a synthetic version of GLP-1, a hormone your gut produces after eating. Learn how semaglutide works at the receptor level. The molecule has been modified so it lasts about a week in your body instead of minutes (like native GLP-1), which is why you only inject once a week.

GLP-1 Mechanism of Action

Appetite Suppression (Central)

Semaglutide crosses the blood-brain barrier and activates GLP-1 receptors in the hypothalamus, particularly in areas controlling hunger and satiety. This reduces appetite, decreases food cravings, and may alter food reward processing. Most users report feeling full faster and thinking about food less.

Gastric Emptying (Peripheral)

GLP-1 activation slows gastric emptying, keeping food in the stomach longer and prolonging satiety after meals. This delay also reduces postprandial glucose spikes. The slower gastric emptying explains common side effects like nausea and early fullness, especially at higher doses.

Insulin & Glucose Regulation

Semaglutide stimulates insulin release from pancreatic beta cells in a glucose-dependent manner, meaning it only increases insulin when blood sugar is elevated, reducing hypoglycemia risk. It also suppresses glucagon secretion, further improving glycemic control in people with diabetes.

Cardiovascular Benefits

The SELECT trial demonstrated that semaglutide 2.4mg reduced major adverse cardiovascular events (heart attack, stroke, cardiovascular death) by 20% in people with obesity and existing cardiovascular disease, even independent of weight loss. GLP-1 receptors in the heart and blood vessels may provide direct cardioprotection.

Pharmacokinetics: Half-Life and Steady State

Half-life: Semaglutide has a half-life of approximately 7 days (1 week), making it ideal for once-weekly dosing. After a dose, drug levels peak around 24-72 hours, then decline slowly.

Steady state: It takes approximately 4-5 weeks of consistent weekly dosing for semaglutide to reach steady-state concentration. This is why each dose level should be maintained for at least 4 weeks before increasing. You need to experience the full effect of that dose before deciding to escalate.

📊 Visualization: Our pharmacokinetics calculator shows your projected drug levels over time, including how long it takes to reach steady state at each dose.

Clinical Trial Data: STEP Program Results

The STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program is the main body of evidence behind semaglutide for weight loss. Here are the key findings:

STEP 1: Primary Weight Loss Trial

1,961 adults with obesity (BMI ≥30) or overweight (BMI ≥27) with weight-related complications, without diabetes, randomized 2:1 to semaglutide 2.4mg or placebo plus lifestyle intervention for 68 weeks.

Average weight loss: 14.9% (semaglutide) vs 2.4% (placebo)
Absolute weight loss: 15.3 kg (33.7 lbs) vs 2.6 kg (5.7 lbs)
≥5% weight loss: 86.4% achieved (vs 31.5% placebo)
≥10% weight loss: 69.1% achieved (vs 12.0% placebo)
≥15% weight loss: 50.5% achieved (vs 4.9% placebo)

Source: Wilding et al., NEJM 2021

STEP 2: Diabetes Population

1,210 adults with type 2 diabetes and obesity randomized to semaglutide 1mg, 2.4mg, or placebo for 68 weeks.

2.4mg weight loss: 9.6% (vs 3.4% placebo)
1mg weight loss: 7.0%
HbA1c reduction: 1.6% (2.4mg) vs 0.4% (placebo)

Note: Weight loss is typically lower in diabetes populations due to insulin's effects on fat storage.

STEP 8: Head-to-Head vs Liraglutide

338 adults randomized to semaglutide 2.4mg weekly or liraglutide 3.0mg daily for 68 weeks.

Semaglutide weight loss: 15.8%
Liraglutide weight loss: 6.4%
Result: Semaglutide produced roughly 2.5x the weight loss of the older daily GLP-1

SELECT: Cardiovascular Outcomes

17,604 adults with obesity and established cardiovascular disease, randomized to semaglutide 2.4mg or placebo, followed for a mean of 39.8 months.

MACE reduction: 20% relative risk reduction (HR 0.80)
Components: Reduced cardiovascular death, nonfatal MI, and nonfatal stroke
FDA label update: Wegovy now approved for cardiovascular risk reduction in eligible patients

Watch: How Semaglutide Works

These videos provide excellent visual explanations of semaglutide's mechanism of action and clinical evidence.

Vox: How semaglutide became the weight loss revolution (3.4M views)

Harvard Medical School: Clinical evidence for GLP-1 agonists

Starting Dose for Semaglutide

The recommended semaglutide starting dose is 0.25mg once weekly. This low initial dose is about tolerability, not efficacy. Skipping the titration or starting higher will almost certainly make you miserable.

Why Start at 0.25mg?

GI adaptation: Your digestive system needs time to adjust to slowed gastric emptying
Nausea: Starting higher leads to severe nausea in most patients
Dropout rates: Proper titration keeps more people on the medication long-term
Receptor adaptation: Gradual exposure lets GLP-1 receptors adjust to continuous stimulation

What to Expect at 0.25mg

At the starting dose, you may notice:

Subtle appetite reduction (if any; some feel nothing at this dose)
Mild nausea, especially after large or fatty meals
Earlier satiety when eating
Minor injection site reactions (redness, mild swelling)

Important: Don't expect significant weight loss at 0.25mg or even 0.5mg. These doses are for adaptation, not efficacy. Most weight loss occurs at 1.7mg and 2.4mg. Be patient with the process.

Semaglutide Titration Schedule

The semaglutide titration schedule follows a 4-week escalation pattern. For a quick visual reference, download our printable semaglutide dosage chart. Each dose increase should only occur if the current dose is well-tolerated.

Week-by-Week Breakdown

Weeks 1-4: 0.25mg/week

Focus on establishing routine. Take your injection on the same day each week, ideally at the same time. Monitor for side effects. Most people feel minimal appetite changes at this dose. Expected weight loss: 0-2 lbs.

Weeks 5-8: 0.5mg/week

First dose increase. May notice increased appetite suppression and more pronounced fullness after meals. Nausea may appear or increase. Eat smaller portions. Expected weight loss: 1-3 lbs.

Weeks 9-12: 1mg/week

Entering therapeutic range for diabetes. Weight loss becomes more noticeable. Many patients experience the most GI side effects at this transition. Expected weight loss: 2-4 lbs.

Weeks 13-16: 1.7mg/week

Approaching maximum dose. Appetite suppression typically strongest. GI symptoms often improve by this point as adaptation occurs. Expected weight loss: 3-5 lbs.

Weeks 17+: 2.4mg/week (Maintenance)

Full therapeutic dose for weight loss. Maximum appetite suppression. Continue at this dose long-term for sustained results. Some patients maintain well at 1.7mg if 2.4mg causes issues.

When to Delay Titration

Consider staying at your current dose longer (6-8 weeks instead of 4) if you experience:

Persistent nausea lasting more than 3-4 days after the dose
Vomiting more than once per week
Inability to eat adequate nutrition
Severe fatigue or weakness
Significant weight loss already (the dose is working, no need to rush)

Pro tip: If you're losing weight steadily at a lower dose with minimal side effects, there's no requirement to reach 2.4mg. Many people achieve excellent results at 1mg or 1.7mg.

Ozempic vs Wegovy: Dosing Differences

Both medications contain the same active ingredient (semaglutide) but differ in their approved doses and indications.

Feature	Ozempic	Wegovy
FDA Indication	Type 2 Diabetes	Chronic Weight Management
Maximum Dose	2mg weekly	7.2mg weekly (2.4mg maintenance)
Available Doses	0.25, 0.5, 1, 2mg	0.25, 0.5, 1, 1.7, 2.4, 7.2mg
CV Risk Reduction	Yes (SUSTAIN-6)	Yes (SELECT trial)
Pen Delivery	Multi-dose pen	Single-dose pens

Key point: For weight loss, the full 2.4mg Wegovy dose produces more weight loss than Ozempic's 2mg max. If you're using compounded semaglutide for weight loss, follow the Wegovy protocol.

Managing Semaglutide Side Effects

Most semaglutide side effects hit the GI tract and get better over time. The STEP 1 trial reported nausea in 44% of participants (vs 17% placebo), but most cases were mild-to-moderate and went away on their own.

Common Side Effects and Solutions

Nausea (44% in trials)

Eat smaller, more frequent meals
Avoid fatty, greasy, or spicy foods
Stop eating at the first sign of fullness
Ginger tea or ginger supplements may help
Stay hydrated. Dehydration worsens nausea

Constipation (24% in trials)

Increase fiber intake (vegetables, fruits, whole grains)
Drink plenty of water. Aim for 64+ oz daily
Consider a fiber supplement (psyllium husk)
Magnesium citrate can help (consult provider)
Stay physically active. Movement helps motility

Diarrhea (30% in trials)

Avoid high-fat foods (especially initially)
Limit caffeine and artificial sweeteners
Stay hydrated. Replace lost fluids
Usually improves as body adapts

Injection Site Reactions

Rotate injection sites (abdomen, thigh, upper arm)
Let alcohol swab dry completely before injecting
Ensure medication is at room temperature
Inject slowly and steadily

When to Seek Medical Attention

Contact a healthcare provider immediately if you experience:

Severe abdominal pain that doesn't go away
Symptoms of pancreatitis (severe upper abdominal pain radiating to back)
Signs of allergic reaction (swelling, difficulty breathing)
Persistent vomiting leading to dehydration
Visual changes (rare: diabetic retinopathy worsening in diabetes patients)

Compounded Semaglutide Considerations

Due to brand-name shortages and high costs, many people obtain compounded semaglutide from 503A or 503B compounding pharmacies. Here's what to know:

Dosing with Compounded Formulations

Same titration applies: Follow the standard Wegovy protocol regardless of source
Concentration matters: Know your vial concentration (e.g., 5mg/mL) to calculate volume
Use a syringe calculator: Our tool helps you draw the correct units for any concentration
Verify quality: Request certificate of analysis (CoA) from your pharmacy

💡 Calculator tip: Enter your vial concentration into our semaglutide calculator to see exactly how many units to draw for each dose. No more math errors.

→ For complete details on compounded options, see our compounded semaglutide guide covering sourcing, quality considerations, pricing, and safety.

Common Compounded Concentrations

Concentration	0.25mg Dose	0.5mg Dose	1mg Dose	2.4mg Dose
2.5mg/mL	10 units	20 units	40 units	96 units
5mg/mL	5 units	10 units	20 units	48 units
10mg/mL	2.5 units	5 units	10 units	24 units

Based on 100-unit insulin syringe. 1 unit = 0.01 mL.

Semaglutide Best Practices

Injection Technique

Inject subcutaneously: Abdomen (2+ inches from navel), front of thighs, or upper arms
Rotate sites: Don't inject in the same spot twice in a row
Same day each week: Pick a consistent day; time of day doesn't matter
With or without food: Semaglutide can be taken regardless of meals
Room temperature: Cold medication stings more. Let it warm up slightly

Lifestyle Optimization

Prioritize protein: Aim for 25-30g protein per meal to preserve muscle mass
Resistance training: Weight loss includes muscle. Strength training helps maintain it
Hydration: 64+ oz water daily; more if exercising or experiencing diarrhea
Fiber balance: Important for gut health but start slowly to avoid GI issues
Monitor vitamins: Reduced food intake may impact B12, iron, and other nutrients

Missed Dose Protocol

Within 5 days of scheduled dose: Take it as soon as you remember, then resume normal schedule
More than 5 days late: Skip the missed dose and take the next one on schedule
Never double up: Don't take two doses to make up for a missed one

Frequently Asked Questions

How long does it take for semaglutide to work?

Most people notice appetite changes within the first 1-2 weeks, even at the starting dose. However, significant weight loss typically begins around weeks 5-8 as doses increase. Maximum effect is usually reached by months 4-5 on the maintenance dose. In clinical trials, weight loss continued through 68 weeks.

Can I stay at a lower dose instead of going to 2.4mg?

Yes. If you're achieving your goals at 1mg or 1.7mg with good tolerability, there's no requirement to reach the maximum dose. The 2.4mg dose provides the most weight loss in trials, but individual response varies. Work with your provider to find your optimal dose.

What happens if I stop taking semaglutide?

Studies show that most people regain a significant portion of lost weight within 1-2 years of discontinuation. This is because semaglutide addresses the biological drivers of obesity while you take it, but those drivers return when you stop. Many providers recommend long-term use or gradual tapering with intensive lifestyle support.

Can I drink alcohol on semaglutide?

Moderate alcohol is generally acceptable, but many users report increased sensitivity. Alcohol may worsen nausea, and with reduced food intake, you may feel effects more strongly. If you have diabetes, monitor blood sugar carefully as alcohol can cause hypoglycemia.

Is semaglutide safe long-term?

Long-term safety data is still building. Semaglutide has been used for diabetes since 2017 (Ozempic) and for weight loss since 2021 (Wegovy). The SELECT cardiovascular trial followed patients for nearly 4 years and showed continued safety plus a 20% reduction in major cardiovascular events. Longer-term studies are ongoing.

How does semaglutide compare to tirzepatide?

Head-to-head trials (SURPASS-2) show tirzepatide produces greater weight loss and HbA1c reduction than semaglutide 1mg. Tirzepatide's dual GLP-1/GIP mechanism appears more potent. However, semaglutide has more long-term safety data and remains an excellent option. See our tirzepatide guide for comparison.

Plan Your Semaglutide Protocol

Our free pharmacokinetics calculator shows your projected drug levels and helps you calculate syringe volumes for compounded medication.

Open Semaglutide Calculator

How to Reconstitute Semaglutide

Step-by-step guide with calculator for compounded peptides

Semaglutide Microdosing Guide

Split dosing strategies for improved tolerability

Understanding GLP-1 Pharmacokinetics

Half-life, steady state, and why it matters

Tirzepatide Dosing Guide

Compare dosing for the dual-agonist alternative

Semaglutide Resource Hub

All semaglutide guides and tools

Medical Disclaimer: This guide is for informational purposes only and does not constitute medical advice. Semaglutide is a prescription medication that should only be used under the supervision of a qualified healthcare provider. Individual results vary. Always consult your doctor before starting, changing, or stopping any medication.